# Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease

> **NCT05904132** · NA · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment

## Interventions

- **DEVICE:** tACS device

## Key facts

- **NCT ID:** NCT05904132
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-31
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05904132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05904132, "Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05904132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*